Olanzapine-induced tardive oculogyric crises

Tardive syndromes are much lower in prevalence in second generation antipsychotics (SGA) than in the typical antipsychotics. Although, olanzapine, which is an SGA, has a high risk of causing weight gain, metabolic syndrome, raised blood sugar, and dyslipidemias; it is widely used as the risk of deve...

Full description

Bibliographic Details
Main Authors: Amar D Bavle, Girish M. N. Kumar
Format: Article
Language:English
Published: SAGE Publishing 2013-01-01
Series:Indian Journal of Psychological Medicine
Subjects:
Online Access:http://www.ijpm.info/article.asp?issn=0253-7176;year=2013;volume=35;issue=4;spage=423;epage=424;aulast=Bavle
_version_ 1818621478341443584
author Amar D Bavle
Girish M. N. Kumar
author_facet Amar D Bavle
Girish M. N. Kumar
author_sort Amar D Bavle
collection DOAJ
description Tardive syndromes are much lower in prevalence in second generation antipsychotics (SGA) than in the typical antipsychotics. Although, olanzapine, which is an SGA, has a high risk of causing weight gain, metabolic syndrome, raised blood sugar, and dyslipidemias; it is widely used as the risk of developing extrapyramidal syndromes (EPS) is low. Among the various forms of EPS, tardive syndromes are the most feared, tardive dyskinesia, tardive akathisia, and tardive dystonia are the commonest tardive syndromes, the others being less common. Tardive oculogyric crises (TOC) are a rare form of tardive dystonia. This patient had TOC with prolonged unsupervised treatment with low-dose olanzapine. Added to that, she developed weight gain that was alarmingly high and such high gain in weight with olanzapine, to our knowledge, has not been reported. She responded to a low dose of trihexiphenydyl, and on stopping olanzapine and adding aripiprazole, has started losing weight.
first_indexed 2024-12-16T18:09:55Z
format Article
id doaj.art-33f81ab26b04422195b1c2c3f2f30e95
institution Directory Open Access Journal
issn 0253-7176
language English
last_indexed 2024-12-16T18:09:55Z
publishDate 2013-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Psychological Medicine
spelling doaj.art-33f81ab26b04422195b1c2c3f2f30e952022-12-21T22:21:48ZengSAGE PublishingIndian Journal of Psychological Medicine0253-71762013-01-0135442342410.4103/0253-7176.122249Olanzapine-induced tardive oculogyric crisesAmar D BavleGirish M. N. KumarTardive syndromes are much lower in prevalence in second generation antipsychotics (SGA) than in the typical antipsychotics. Although, olanzapine, which is an SGA, has a high risk of causing weight gain, metabolic syndrome, raised blood sugar, and dyslipidemias; it is widely used as the risk of developing extrapyramidal syndromes (EPS) is low. Among the various forms of EPS, tardive syndromes are the most feared, tardive dyskinesia, tardive akathisia, and tardive dystonia are the commonest tardive syndromes, the others being less common. Tardive oculogyric crises (TOC) are a rare form of tardive dystonia. This patient had TOC with prolonged unsupervised treatment with low-dose olanzapine. Added to that, she developed weight gain that was alarmingly high and such high gain in weight with olanzapine, to our knowledge, has not been reported. She responded to a low dose of trihexiphenydyl, and on stopping olanzapine and adding aripiprazole, has started losing weight.http://www.ijpm.info/article.asp?issn=0253-7176;year=2013;volume=35;issue=4;spage=423;epage=424;aulast=BavleAripiprazoleolanzapinetardive oculogyric crisestrihexiphenidylweight gain
spellingShingle Amar D Bavle
Girish M. N. Kumar
Olanzapine-induced tardive oculogyric crises
Indian Journal of Psychological Medicine
Aripiprazole
olanzapine
tardive oculogyric crises
trihexiphenidyl
weight gain
title Olanzapine-induced tardive oculogyric crises
title_full Olanzapine-induced tardive oculogyric crises
title_fullStr Olanzapine-induced tardive oculogyric crises
title_full_unstemmed Olanzapine-induced tardive oculogyric crises
title_short Olanzapine-induced tardive oculogyric crises
title_sort olanzapine induced tardive oculogyric crises
topic Aripiprazole
olanzapine
tardive oculogyric crises
trihexiphenidyl
weight gain
url http://www.ijpm.info/article.asp?issn=0253-7176;year=2013;volume=35;issue=4;spage=423;epage=424;aulast=Bavle
work_keys_str_mv AT amardbavle olanzapineinducedtardiveoculogyriccrises
AT girishmnkumar olanzapineinducedtardiveoculogyriccrises